PHX 4.17% 4.6¢ pharmx technologies limited

Ann: Annual Report to shareholders, page-2

  1. 4,208 Posts.
    lightbulb Created with Sketch. 462
    A positive report, particularly with some upbeat commentary from the Chairman and MD.

    Highlights for me included:
    - After tax profit of $251k in a year of transition
    - Corum Clear is fully developed and ready to be launched to the market
    - Other products developed (Safeguard and ARCScript) are contributing to revenue with take-up of 30% of customers. To me that says there are still potential targets for an upsell
    - Costs decreased over the year, Chairman suggests these could reduce by another 15% this year. This is roughly $2m off the current cost base, which post development of Corum Clear is understandable.
    - Targeting revenue growth of 10%, which combined with the cost savings, would see revenues of $14m and costs of $10m, so a potential $4m in net profit after tax without taking into account any one-offs.
    - Mergers and acqusitions are still being reviewed.
    - Cash at the end of this quarter is expected to be $6.7m

    For the first time in while, things are looking up. A good half year result and an interim dividends might even be on the cards.
 
watchlist Created with Sketch. Add PHX (ASX) to my watchlist
(20min delay)
Last
4.6¢
Change
-0.002(4.17%)
Mkt cap ! $27.53M
Open High Low Value Volume
4.6¢ 4.6¢ 4.6¢ $16.1K 350K

Buyers (Bids)

No. Vol. Price($)
2 200000 4.3¢
 

Sellers (Offers)

Price($) Vol. No.
4.8¢ 89390 1
View Market Depth
Last trade - 13.11pm 13/09/2024 (20 minute delay) ?
PHX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.